Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Med ; 117(3): 163-8, 2004 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-15276594

RESUMEN

BACKGROUND: Studies of interferon-based therapies for hepatitis C virus (HCV)-infected patients have documented variable response rates according to ethnicity. However, these studies enrolled low numbers of ethnic minorities. METHODS: Data from two multicenter trials of combination therapy for hepatitis C were analyzed to determine predictors of treatment success. The first trial was a randomized study comparing interferon administered three times weekly with daily administration. Patients in both interferon groups received weight-based ribavirin. The second trial was an observational study of daily interferon and ribavirin. Only treatment-naïve patients were included in the analysis. Ethnicity (used as a nonspecific term to include race) was determined by patient self-report. Sustained virologic response was defined as negative HCV RNA by polymerase chain reaction at 24 weeks after completion of therapy. RESULTS: A total of 661 patients (390 from the randomized trial and 271 from the observational trial) were available for analysis. Sustained virologic response was highest among Asians (61% [22/36]), followed by whites (39% [193/496]), Hispanics (23% [18/79]), and African Americans (14% [7/50]). In a multiple logistic regression model that adjusted for other factors known to affect treatment outcome, including hepatitis C genotype, Asians continued to be more likely to respond to treatment, whereas Hispanics and African Americans were less likely, as compared with whites. CONCLUSION: Sustained response rates to interferon and ribavirin therapy differ among ethnic groups. Ethnicity appears to be associated with treatment outcomes, even in a model that adjusts for other factors that influence response to therapy.


Asunto(s)
Etnicidad , Hepatitis C Crónica/tratamiento farmacológico , Adulto , Negro o Afroamericano , Asiático , Femenino , Hispánicos o Latinos , Humanos , Interferones/uso terapéutico , Masculino , Persona de Mediana Edad , Ribavirina/uso terapéutico , Resultado del Tratamiento , Población Blanca
2.
Int J STD AIDS ; 15(2): 127-33, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15006076

RESUMEN

A retrospective review was conducted on serum vitamin B12 levels in an HIV-infected outpatient cohort, many of whom received antiretroviral therapy. B12 levels were obtained at most staging visits (every six months) and when clinically indicated. For each serum B12 level, laboratory values and clinical symptoms were recorded. Thirty-two patients (32/251 or 13%) had at least one low B12 level (<211pg/mL) during the course of their HIV infection. Within two years of their initial HIV presentation, 6/57 patients had a low serum B12. Using multiple linear regression analysis, a higher serum B12 level was significantly associated with higher folate levels, African-American race, and lower mean corpuscular volume. B12 levels increased significantly after initiating antiretroviral therapy (416 vs 535 pg/mL, P=0.04). In conclusion, low serum B12 levels occur commonly among HIV-infected patients, even at early stages without overt symptoms of B12 deficiency. Antiretroviral therapy may increase serum B12 levels.


Asunto(s)
Infecciones por VIH/complicaciones , Deficiencia de Vitamina B 12/sangre , Deficiencia de Vitamina B 12/epidemiología , Vitamina B 12/sangre , Adulto , Atención Ambulatoria , Antirretrovirales/uso terapéutico , Etnicidad , Femenino , Hospitales Militares , Humanos , Masculino , Registros Médicos , Personal Militar/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo , Texas/epidemiología , Deficiencia de Vitamina B 12/complicaciones , Deficiencia de Vitamina B 12/etnología
3.
Am J Epidemiol ; 155(5): 406-12, 2002 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11867351

RESUMEN

Small, inexpensive, often poorly made handguns known as "Saturday night specials" are disproportionately involved in crime. Maryland banned the sale of Saturday night specials effective January 1, 1990. During the 2 years between the law's passage in 1988 and its effective date, legal handgun sales in Maryland were 34% higher than expected (p = 0.09). Interrupted time-series analysis of age-adjusted homicide rates for 1975-1998 with statistical controls for trends in two neighboring states, social and economic variables, and temporal patterns in Maryland's homicide rates was used to assess the effect of the law. Estimates of the Saturday night special ban effects depended on the assumption made about the timing of the law's effects. Models that assumed a delayed or gradual effect of the Saturday night special ban produced estimates indicating that firearm homicide rates were 6.8-11.5% lower than would have been expected without the Saturday night special ban (p < or =0.05). The model that assumed an immediate, constant change in response to the law showed no law effect, unless an outlier was excluded from the analysis. Excluding this outlier, the model estimated a 15% increase in firearm homicides associated with the Saturday night special ban. None of the models revealed significant law effects on nonfirearm homicides.


Asunto(s)
Armas de Fuego/legislación & jurisprudencia , Homicidio/estadística & datos numéricos , Predicción , Humanos , Incidencia , Maryland/epidemiología , Modelos Teóricos , Política Pública , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA